Chardan Capital Markets Starts Hyperliquid Strategies, Inc. (PURR) at Buy Dec 24, 2025 06:00AM
Hyperliquid Strategies completes business combination with Sonnet BioTherapeutics Dec 2, 2025 04:31PM
Hyperliquid Strategies Inc and Sonnet BioTherapeutics Holdings, Inc. Announce Closing of Business Combination Dec 2, 2025 04:30PM